PubRank

Michael H Criqui

Author PubWeight™ 431.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 56.72
2 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 41.47
3 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 26.95
4 Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012 11.32
5 The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013 10.43
6 Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009 8.11
7 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 7.99
8 Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013 7.03
9 Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011 6.36
10 Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015 6.13
11 Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 2012 5.41
12 Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2003 4.52
13 Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol 2004 4.43
14 Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004 4.27
15 Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol 2010 4.10
16 Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009 3.83
17 Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 2005 3.81
18 Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012 3.39
19 The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002 3.32
20 Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013 3.02
21 Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006 2.81
22 Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2005 2.75
23 Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med 2006 2.73
24 Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2003 2.72
25 Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation 2007 2.63
26 Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 2007 2.63
27 The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009 2.53
28 Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006 2.40
29 Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol 2009 2.37
30 Peripheral arterial disease: morbidity and mortality implications. Circulation 2006 2.37
31 Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med 2008 2.24
32 The vital prognosis of subclavian stenosis. J Am Coll Cardiol 2007 2.10
33 Prevalence of and risk factors for subclinical cardiovascular disease in selected US Hispanic ethnic groups: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2008 2.04
34 Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation 2006 2.02
35 Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med 2008 2.01
36 Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation 2010 1.97
37 Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc 2007 1.92
38 The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes. Control Clin Trials 2004 1.90
39 Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J Am Coll Cardiol 2008 1.84
40 Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension 2007 1.83
41 Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol 2008 1.82
42 Fine particulate matter air pollution, proximity to traffic, and aortic atherosclerosis. Epidemiology 2009 1.81
43 Abdominal aortic calcium and multi-site atherosclerosis: the Multiethnic Study of Atherosclerosis. Atherosclerosis 2010 1.79
44 The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 2008 1.78
45 Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2011 1.72
46 Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2010 1.71
47 The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004 1.70
48 Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association. Circulation 2010 1.69
49 Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation 2006 1.68
50 Blood pressure and vascular calcification. Hypertension 2010 1.68
51 The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006 1.68
52 Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol 2007 1.67
53 American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation 2013 1.66
54 Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg 2009 1.59
55 Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med 2004 1.57
56 Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg 2007 1.57
57 Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 2008 1.54
58 Bicc1 is a genetic determinant of osteoblastogenesis and bone mineral density. J Clin Invest 2014 1.53
59 Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 2003 1.51
60 A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. J Am Coll Cardiol 2008 1.50
61 Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Arch Intern Med 2004 1.50
62 Greater sedentary hours and slower walking speed outside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease. J Am Coll Cardiol 2011 1.49
63 Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 1.46
64 Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. Am J Epidemiol 2008 1.45
65 Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis 2005 1.42
66 Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation 2004 1.42
67 Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study. COPD 2011 1.41
68 The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 2008 1.37
69 Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg 2008 1.36
70 Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA 2013 1.35
71 Physical activity during daily life and functional decline in peripheral arterial disease. Circulation 2008 1.34
72 N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail 2012 1.31
73 Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). J Am Coll Cardiol 2009 1.30
74 Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2011 1.30
75 Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002 1.30
76 Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis. J Am Coll Cardiol 2007 1.29
77 Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance. J Vasc Surg 2004 1.29
78 Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 2011 1.26
79 Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol 2011 1.25
80 Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003 1.25
81 Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2004 1.24
82 Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc 2003 1.24
83 Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol 2009 1.23
84 Ethnic-specific risks for atherosclerotic calcification of the thoracic and abdominal aorta (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2009 1.22
85 Exertional leg pain in patients with and without peripheral arterial disease. Circulation 2005 1.22
86 D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003 1.22
87 Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol 2006 1.20
88 Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc 2008 1.20
89 Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med 2002 1.19
90 Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med 2003 1.16
91 A high ankle brachial index is associated with greater left ventricular mass MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010 1.16
92 D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2005 1.16
93 Lower extremity performance is associated with daily life physical activity in individuals with and without peripheral arterial disease. J Am Geriatr Soc 2002 1.14
94 Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler Thromb Vasc Biol 2005 1.14
95 Lower extremity nerve function in patients with lower extremity ischemia. Arch Intern Med 2006 1.14
96 Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol 2011 1.14
97 Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. Arch Intern Med 2005 1.14
98 CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation 2004 1.13
99 Quality of life in patients with chronic venous disease: San Diego population study. J Vasc Surg 2003 1.13
100 Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation 2008 1.12
101 Obesity, weight change, and functional decline in peripheral arterial disease. J Vasc Surg 2006 1.12
102 Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease. Circulation 2009 1.12
103 Low and lowered cholesterol and total mortality. J Am Coll Cardiol 2004 1.10
104 Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J 2006 1.10
105 Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol 2007 1.09
106 The epidemiology of subclavian stenosis and its association with markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2010 1.09
107 The general prognosis of patients with peripheral arterial disease differs according to the disease localization. J Am Coll Cardiol 2010 1.06
108 Relation of leptin to left ventricular hypertrophy (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2013 1.05
109 Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. J Am Coll Cardiol 2012 1.04
110 Large and small vessels atherosclerosis: similarities and differences. Prog Cardiovasc Dis 2007 1.04
111 Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study. Atherosclerosis 2009 1.03
112 Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women. Metabolism 2003 1.03
113 The epidemiology of abdominal aortic diameter. J Vasc Surg 2008 1.03
114 Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. JACC Cardiovasc Imaging 2013 1.03
115 Recruiting participants with peripheral arterial disease for clinical trials: experience from the Study to Improve Leg Circulation (SILC). J Vasc Surg 2009 1.03
116 Triglycerides and coronary heart disease revisited (again). Ann Intern Med 2007 1.02
117 The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients. J Vasc Surg 2007 1.01
118 The relevance of different methods of calculating the ankle-brachial index: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2009 1.01
119 Baseline lower extremity strength and subsequent decline in functional performance at 6-year follow-up in persons with lower extremity peripheral arterial disease. J Am Geriatr Soc 2009 1.00
120 Stability of physical activity across the lifespan. J Health Psychol 2008 0.99
121 Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative. Circulation 2004 0.98
122 Test characteristics of the ankle-brachial index and ankle-brachial difference for medial arterial calcification on X-ray in type 1 diabetes. J Vasc Surg 2012 0.98
123 Renal artery calcium is independently associated with hypertension. J Am Coll Cardiol 2007 0.97
124 Peripheral arterial disease in African Americans: clinical characteristics, leg symptoms, and lower extremity functioning. J Am Geriatr Soc 2004 0.97
125 Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study. J Am Coll Cardiol 2011 0.96
126 Sex hormones, sex hormone binding globulin, and abdominal aortic calcification in women and men in the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2008 0.96
127 The differential association of kidney dysfunction with small and large arterial elasticity: the multiethnic study of atherosclerosis. Am J Epidemiol 2009 0.96
128 Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer. J Gerontol A Biol Sci Med Sci 2006 0.95
129 Relation of retinopathy to coronary artery calcification: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2007 0.95
130 The association between abdominal body composition and vascular calcification. Obesity (Silver Spring) 2011 0.95
131 Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis. Clin Chem 2012 0.95
132 Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? Circulation 2008 0.95
133 Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race. J Vasc Surg 2005 0.95
134 34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J Am Coll Cardiol 2003 0.94
135 Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2004 0.94
136 Genetic ancestry and lower extremity peripheral artery disease in the Multi-Ethnic Study of Atherosclerosis. Vasc Med 2010 0.94
137 Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc 2008 0.94
138 Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vasc Med 2009 0.94
139 The association between physical activity and both incident coronary artery calcification and ankle brachial index progression: the multi-ethnic study of atherosclerosis. Atherosclerosis 2013 0.93
140 Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol 2011 0.93
141 Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) study. Am J Epidemiol 2010 0.93
142 Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease. J Vasc Surg 2007 0.92
143 Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease. Am J Cardiol 2008 0.92
144 Coronary heart disease risks associated with high levels of HDL cholesterol. J Am Heart Assoc 2014 0.92
145 The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease. J Vasc Surg 2012 0.91
146 Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 2003 0.91
147 Alcohol consumption and lower extremity arterial disease among older adults: the cardiovascular health study. Am J Epidemiol 2007 0.91
148 The effects of continuing medical education credits on physician response rates to a mailed questionnaire. Health Mark Q 2003 0.91
149 The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vasc Med 2010 0.90
150 Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study. Circ Heart Fail 2009 0.90
151 Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med 2005 0.90
152 Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease. Vasc Med 2004 0.89
153 Association of self-reported race/ethnicity and genetic ancestry with arterial elasticity: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Soc Hypertens 2011 0.89
154 Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease. Adv Chronic Kidney Dis 2008 0.89
155 Can we improve cardiovascular risk prediction beyond risk equations in the physician's office? J Clin Epidemiol 2006 0.88
156 Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc 2010 0.88
157 Superficial femoral artery plaque and functional performance in peripheral arterial disease: walking and leg circulation study (WALCS III). JACC Cardiovasc Imaging 2011 0.88
158 Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study. J Clin Endocrinol Metab 2013 0.88
159 Declining walking impairment questionnaire scores are associated with subsequent increased mortality in peripheral artery disease. J Am Coll Cardiol 2013 0.87
160 The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and observational study samples. BMJ Open 2012 0.87
161 Progression of asymptomatic peripheral artery disease over 1 year. Vasc Med 2012 0.87
162 Renal artery calcification and mortality among clinically asymptomatic adults. J Am Coll Cardiol 2012 0.86
163 Renal artery calcium: relationship to systemic calcified atherosclerosis. Vasc Med 2006 0.86
164 Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study. Am J Epidemiol 2011 0.86
165 24-hour urine phosphorus excretion and mortality and cardiovascular events. Clin J Am Soc Nephrol 2013 0.86
166 Metabolic syndrome and risk of incident peripheral artery disease: the cardiovascular health study. Hypertension 2013 0.85
167 Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients. J Am Coll Cardiol 2007 0.85
168 Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study. Contemp Clin Trials 2013 0.85
169 Superficial femoral artery plaque, the ankle-brachial index, and leg symptoms in peripheral arterial disease: the walking and leg circulation study (WALCS) III. Circ Cardiovasc Imaging 2011 0.85
170 A pilot exercise intervention to improve lower extremity functioning in peripheral arterial disease unaccompanied by intermittent claudication. J Cardiopulm Rehabil 2004 0.84
171 Associations of calf skeletal muscle characteristics and peripheral nerve function with self-perceived physical functioning and walking ability in persons with peripheral artery disease. Vasc Med 2011 0.84
172 The Group Oriented Arterial Leg Study (GOALS) to improve walking performance in patients with peripheral arterial disease. Contemp Clin Trials 2012 0.84
173 Comparison of ordinal versus Agatston coronary calcification scoring for cardiovascular disease mortality in community-living individuals. Int J Cardiovasc Imaging 2014 0.84
174 Leg strength predicts mortality in men but not in women with peripheral arterial disease. J Vasc Surg 2010 0.84
175 Associations of noninvasive measures of arterial compliance and ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens 2012 0.84
176 Ankle-brachial index (ABI), abdominal aortic calcification (AAC), and coronary artery calcification (CAC): the Jackson heart study. Int J Cardiovasc Imaging 2012 0.83
177 Lower extremity nerve function, calf skeletal muscle characteristics, and functional performance in peripheral arterial disease. J Am Geriatr Soc 2011 0.82
178 The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis. J Bone Miner Res 2011 0.82
179 The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease. J Vasc Surg 2011 0.82
180 Poorer clock draw test scores are associated with greater functional impairment in peripheral artery disease: the Walking and Leg Circulation Study II. Vasc Med 2011 0.81
181 Comparative effectiveness study of self-directed walking exercise, lower extremity revascularization, and functional decline in peripheral artery disease. J Vasc Surg 2013 0.80
182 Risk marker associations with venous thrombotic events: a cross-sectional analysis. BMJ Open 2014 0.80
183 Comparison of effects of statin use on mortality in patients with peripheral arterial disease with versus without elevated C-reactive protein and d-dimer levels. Am J Cardiol 2010 0.80
184 Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Metabolism 2013 0.79
185 Higher body mass index is associated with more adverse changes in calf muscle characteristics in peripheral arterial disease. J Vasc Surg 2012 0.79
186 Vitamin D status, functional decline, and mortality in peripheral artery disease. Vasc Med 2014 0.79
187 Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. Atherosclerosis 2012 0.79
188 Relation of interleukin-6 and vascular cellular adhesion molecule-1 levels to functional decline in patients with lower extremity peripheral arterial disease. Am J Cardiol 2011 0.78
189 The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease. Vasc Med 2004 0.78
190 Obesity, risk factors, and predicting cardiovascular events. Circulation 2005 0.78
191 Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary. Circulation 2008 0.78
192 Aspirin and secondary prevention in peripheral artery disease: a perspective for the early 21st century. JAMA 2009 0.77
193 Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2013 0.76
194 Noncontrast cardiac computed tomography image-based vertebral bone mineral density: the Multi-Ethnic Study of Atherosclerosis (MESA). Acad Radiol 2013 0.76
195 Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. J Clin Psychopharmacol 2016 0.75
196 Highs and lows in the peripheral vasculature. J Am Coll Cardiol 2012 0.75
197 Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2016 0.75
198 Response to Hiatt et al. Circulation 2014 0.75
199 Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population Study. Thromb Res 2012 0.75
200 Quantified duplex augmentation in healthy subjects and patients with venous disease: San Diego population study. J Vasc Surg 2003 0.75
201 Vitamin D status and functional performance in peripheral artery disease. Vasc Med 2012 0.75
202 Burden of Peripheral Artery Disease on Mortality and Incident Cardiovascular Events. Am J Epidemiol 2020 0.75